The Ser1369Ala Variant of ABCC8 and the Risk for Severe Sulfonylurea-Induced Hypoglycemia In German Patients with Type 2 Diabetes

Abstract

A letter in response to: Sato R, Watanabe H, Genma R et al.ABCC8 polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas. Pharmacogenomics 11(12), 1743–1750 (2010).

Acknowledgements

The authors thank I Müller and B Enigk for their excellent technical assistance.

Disclaimer

This work is the opinion of the authors and does not represent the views of Future Medicine or its employees.

Financial & competing interest disclosure

This work was supported by grants from the Deutsche Forschungsgemeinschaft (KFO-152 ‘Atherobesity‘ to M Stumvoll)and from the German Diabetes Association (to P Kovacs). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Ethical conduct of research

The authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.

Additional information

Funding

This work was supported by grants from the Deutsche Forschungsgemeinschaft (KFO-152 ‘Atherobesity‘ to M Stumvoll)and from the German Diabetes Association (to P Kovacs). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.